ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,174Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 206

$1.04M Total Retail Price of All Prescriptions

Rank: 1 out of 206

372 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 372 patients filled at least one prescription for a schedule two drug, compared to an average of 15%.

Schedule Three
Controlled Substances

26% of this provider’s 372 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 11,542 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

39% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
SIMVASTATIN 723 615 1 5
METFORMIN HCL 523 417 2 6
AMLODIPINE BESYLATE 497 413 3 8
OMEPRAZOLE 435 357 4 4
NEXIUM 417 388 5 50
FUROSEMIDE 379 276 6 7
LISINOPRIL 350 280 7 2
LEVOTHYROXINE SODIUM 313 220 8 3
ALENDRONATE SODIUM 293 285 9 47
HYDROCODONE-ACETAMINOPHEN 285 227 S3 10 1
ZOLPIDEM TARTRATE 276 225 11 24
LIDODERM 276 274 11 63
HYDROCHLOROTHIAZIDE 261 209 13 9
ATORVASTATIN CALCIUM 236 186 14 15
CELEBREX 234 180 15 72
LYRICA 200 165 16 66
BYSTOLIC 196 163 17 58
GABAPENTIN 188 111 18 12
DIOVAN HCT 186 170 19 95
TRILIPIX 185 150 20 97
FLUOXETINE HCL 170 145 21 45
CYMBALTA 167 87 22 46
NAMENDA 159 155 23 87
TAMSULOSIN HCL 157 154 24 31
TRAMADOL HCL 151 139 25 27
DIOVAN 149 141 26 77
CRESTOR 141 130 27 38
SINGULAIR 138 88 28 89
RANITIDINE HCL 134 113 29 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 133 83 30 51
CARVEDILOL 132 86 31 11
LOSARTAN POTASSIUM 121 100 32 20
AVODART 120 120 33 122
LANTUS SOLOSTAR 120 95 33 68
FLUTICASONE PROPIONATE 117 106 35 54
METOPROLOL SUCCINATE 116 90 36 18
ATELVIA 110 100 37 130
POTASSIUM CHLORIDE 107 42 38 16
TIZANIDINE HCL 106 81 39 44
SPIRIVA 103 84 40 52
PRAVASTATIN SODIUM 96 76 41 25
ALLOPURINOL 93 84 42 82
LIPITOR 92 87 43 111
GLIPIZIDE ER 91 78 44 140
ATENOLOL-CHLORTHALIDONE 85 85 45 141
ADVAIR DISKUS 82 59 46 32
ACETAMINOPHEN-CODEINE 80 77 S3 47 112
ATENOLOL 76 59 48 17
DONEPEZIL HCL 75 75 49 147
PLAVIX 74 70 50 61
SERTRALINE HCL 71 62 51 34
ULORIC 71 71 51 152
ACTOS 68 56 53 155
PEN NEEDLE 67 67 54 124
METOPROLOL TARTRATE 66 27 55 14
MONTELUKAST SODIUM 65 39 56 159
PROAIR HFA 63 49 57 37
GLIPIZIDE XL 59 53 58 168
OXYBUTYNIN CHLORIDE ER 59 59 58 168
NIFEDIPINE ER 56 44 60 175
HUMALOG 55 49 61 75
JANUVIA 55 45 61 88
TRIAMCINOLONE ACETONIDE 53 48 63 55
LOVASTATIN 52 52 64 13
MELOXICAM 51 37 65 62
PRAMIPEXOLE DIHYDROCHLORIDE 51 51 65 188
FLECTOR 50 45 67 191
ISOSORBIDE DINITRATE 50 50 67 191
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 11, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.